Clinical Trial Update: Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the activity and safety of a non-chemotherapy-based combination of lenalidomide and rituximab in chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: MD Anderson International Spain SA | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED